Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study-Reference-Cited by-同舟云学术

Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: a retrospective cohort study

Published:2023-03 Issue:3 Volume:5 Page:e139-e150
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Qian Grace,Wang Xiaosong,Patel Naomi J,Kawano Yumeko,Fu Xiaoqing,Cook Claire E,Vanni Kathleen M M,Kowalski Emily N,Banasiak Emily P,Bade Katarina J,Srivatsan Shruthi,Williams Zachary K,Todd Derrick J,Weinblatt Michael E,Wallace Zachary S,Sparks Jeffrey A

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference32 articles.

1. REGEN-COV antibody combination and outcomes in outpatients with COVID-19;Weinreich;N Engl J Med,2021

2. Early remdesivir to prevent progression to severe COVID-19 in outpatients;Gottlieb;N Engl J Med,2022

3. Oral nirmatrelvir for high-risk, nonhospitalized adults with COVID-19;Hammond;N Engl J Med,2022

4. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients;Jayk Bernal;N Engl J Med,2022

5. Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study;Deepak;Ann Intern Med,2021

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 real world data infrastructure: A big data resource for study of the impact of COVID-19 in patient populations with immunocompromising conditions;2024-09-09

2. Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies;Journal of Autoimmunity;2024-09

3. The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19;Journal of Infection;2024-09

4. Nirmatrelvir/Ritonavir Regimen for Mild/Moderately Severe COVID-19: A Rapid Review With Meta-Analysis and Trial Sequential Analysis;The Annals of Family Medicine;2024-07

5. Effectiveness of Nirmatrelvir-Ritonavir for the Prevention of COVID-19–Related Hospitalization and Mortality: A Systematic Literature Review;American Journal of Therapeutics;2024-04-29